Common warts market seen reaching $2.96 billion by 2030
The global common warts market is projected to grow from $2.25 billion in 2025 to $2.96 billion by 2030, driven by rising HPV infections, broader dermatology access and growing demand for non-invasive treatments. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.
Why it matters: - The common warts market is tied to rising viral infection rates, especially human papillomavirus, which is increasing demand for treatment. - Growth in dermatology care is expanding access to cryotherapy, topical salicylic acid and newer non-invasive options. - The market outlook signals continued investment in skin health, cosmetic dermatology and home-based care products.
What happened: - The Business Research Company projected the common warts market will rise from $2.25 billion in 2025 to $2.38 billion in 2026. - The report forecasts the market will reach about $2.96 billion by 2030, implying a 5.6% compound annual growth rate from 2026 to 2030. - The report said historical growth has been supported by HPV infection rates, cryotherapy use, salicylic acid treatments, dermatology clinic expansion and greater public awareness of skin health. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.
The details: - Common warts are benign skin growths caused by HPV infection. - The growths often appear on the hands and fingers. - Common warts can cause discomfort and cosmetic concerns, which pushes treatment demand. - The report identified a growing preference for non-invasive dermatological procedures. - The report also flagged rising interest in cosmetic dermatology, homecare dermatology products, laser-based therapies and immunomodulatory treatments. - Notable trends include minimally invasive wart removal technologies, combined treatment approaches, broader over-the-counter access and immunotherapy-based topical solutions. - Home-based treatment alternatives are expected to improve patient convenience and access. - The report covered North America, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report also added market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report offered a free sample at Download a free sample of the common warts market report. - The full report is available at View the full common warts market report.
Between the lines: - The market’s growth is being driven by treatment demand, not just disease incidence. - The report’s emphasis on homecare, over-the-counter and minimally invasive options suggests vendors are competing on convenience as much as clinical efficacy. - The regional split points to mature demand in North America and faster adoption potential in emerging Asia-Pacific markets. - The report cited CDC data showing PCR-confirmed varicella cases in the U.S. increased by 62% from 29% to 47% over the last five years. - The National Foundation for Infectious Diseases estimated about 14 million new HPV infections annually in the U.S.
What's next: - Demand is likely to keep rising as patients seek easier, less invasive and more accessible wart treatments. - Future market gains will likely depend on the adoption of laser therapies, immunotherapy-based topicals and combined treatment protocols. - Wider availability of home-based care products could expand treatment access beyond dermatology clinics.
The bottom line: - The common warts market is on a steady growth path, with infection prevalence, convenience-focused treatments and broader dermatology access shaping the next phase of expansion.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Middle East News Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.